Compared with untreated control, lactate levels after treatment of DMAMCL treatment significantly decreased (Figure 3D), indicating that DMAMCL promotes the formation of the active tetrameric PKM2, subsequently decreasing the lactate production in GBM cells. This evidence concerns the gene PKM and glioblastoma.